Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation
Author:
Affiliation:
1. School of Medicine, Nankai University, Tianjin, China
2. Tianjin Tasly Pride Pharmaceutical Co., Ltd., Tianjin, China
3. Tianjin Key Laboratory of Safety Evaluation Enterprise of TCM Injections, Tianjin, China
Funder
Science and Technology enterprises served by the Science and Technology Commissioners System in Tianjin and Tianjin Science and Technology Plan Project
Publisher
Informa UK Limited
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13880209.2022.2038207
Reference32 articles.
1. The case for inhibiting p38 mitogen-activated protein kinase in heart failure
2. Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
3. The annual global economic burden of heart failure
4. Cardiac Overexpression of a G q Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH 2 -Terminal Kinase Activity in In Vivo Pressure Overload
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment with a combination of myricitrin and exercise alleviates myocardial infarction in rats via suppressing Nrf2/HO-1 antioxidant pathway;Archives of Biochemistry and Biophysics;2024-09
2. The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods;Biomedicine & Pharmacotherapy;2024-08
3. Design and therapeutic application of trans‐sodium crocetinate‐loaded cyclodextrin metal–organic frameworks as an enteric preparation for treating chronic heart failure;Applied Organometallic Chemistry;2024-03-28
4. YiQiFuMai Injection Ameliorated Sepsis-induced Cardiomyopathy by Inhibition of Ferroptosis via xCT/GPX4 Axis;Shock;2023-11-16
5. Xinbao Pill attenuated chronic heart failure by suppressing the ubiquitination of β-adrenergic receptors;Phytomedicine;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3